BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/5/2026 8:51:02 AM | Browse: 3 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
From local eradication to immune priming: Paradigm shift of hyperthermic intraperitoneal chemotherapy in gastric cancer therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chun-Xiao Ni and Jia-Ju Xu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Scientific Research Fund of Tai’an Science and Technology Agency |
No. 2019NS180 |
|
| Corresponding Author |
Jia-Ju Xu, MD, Department of Medical Oncology, Tai’an City Central Hospital, No. 29 Longtan Road, Tai’an 271000, Shandong Province, China. jiajuxu1101@163.com |
| Key Words |
Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Tumor immune microenvironment; Immunogenic cell death; Immune checkpoint inhibitors |
| Core Tip |
Postoperative hyperthermic intraperitoneal chemotherapy should be reconceptualized as an immunogenic primer that activates systemic anti-tumor immunity, rather than be viewed merely as a local cytoreductive treatment. This repositions hyperthermic intraperitoneal chemotherapy as a strategic foundation for synergistic combination with immune-checkpoint inhibitors. Consequently, future research should prioritize the definition of optimal synergistic sequences and the identification of predictive biomarkers to pave the way for this precision immunotherapy strategy. |
| Citation |
Ni CX, Xu JJ. From local eradication to immune priming: Paradigm shift of hyperthermic intraperitoneal chemotherapy in gastric cancer therapy. World J Gastroenterol 2026; In press |
 |
Received |
|
2025-12-30 06:09 |
 |
Peer-Review Started |
|
2025-12-30 06:10 |
 |
First Decision by Editorial Office Director |
|
2026-01-07 10:28 |
 |
Return for Revision |
|
2026-01-07 10:28 |
 |
Revised |
|
2026-01-13 12:22 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-02-05 02:47 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-05 08:51 |
 |
Articles in Press |
|
2026-02-05 08:51 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345